Target Name: LOC730098
NCBI ID: G730098
Review Report on LOC730098 Target / Biomarker Content of Review Report on LOC730098 Target / Biomarker
LOC730098
Other Name(s): uncharacterized LOC730098 | LOC730098 variant 1 | Uncharacterized protein LOC730098 | Uncharacterized LOC730098, transcript variant 1

LOC730098: A Protein Involved in Brain Function and Addiction

LOC730098 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to be involved in the regulation of cellular processes that are important for brain function, such as the formation of new neurons and the regulation of neurotransmitter release.

Recent studies have suggested that LOC730098 may be a drug target or biomarker for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. This is because the protein is known to be involved in the development and progression of these conditions, and may play a role in the development of symptoms associated with these disorders.

One of the key functions of LOC730098 is its role in the regulation of neurotransmitter release from nerve cells. This is important for the proper functioning of the brain, as neurotransmitters are the chemical messengers that carry signals between neurons. If the release of these messengers is not properly regulated, it can lead to a range of neurological and psychiatric symptoms, including depression, anxiety, and cognitive impairments.

Studies have shown that LOC730098 is involved in the regulation of the release of dopamine, a neurotransmitter that is involved in mood, emotion, and motivation. In addition, LOC730098 has been shown to play a role in the regulation of the release of other neurotransmitters, including serotonin and endocannabinoid.

The role of LOC730098 in the regulation of neurotransmitter release is also important for the development of addiction. Studies have shown that LOC730098 is involved in the regulation of the release of dopamine from the brain, and that this may contribute to the development of addiction. Additionally, LOC730098 has been shown to be involved in the regulation of the release of other neurotransmitters that are involved in addiction, including GABA and glutamate.

In addition to its role in the regulation of neurotransmitter release, LOC730098 is also involved in the regulation of cellular processes that are important for brain function. This includes the formation of new neurons, which is important for the development and maintenance of a healthy brain.

Studies have shown that LOC730098 is involved in the regulation of the formation of new neurons in the brain, and that this may play a role in the development of neurological and psychiatric disorders. Additionally, LOC730098 has been shown to play a role in the regulation of the growth and differentiation of neural stem cells, which are important for the development and maintenance of the nervous system.

Finally, LOC730098 is also involved in the regulation of the immune response, which is important for the health and function of the brain. Studies have shown that LOC730098 is involved in the regulation of the production of antibodies, which are proteins that help to protect the body against infection.

In conclusion, LOC730098 is a protein that is involved in a wide range of cellular processes that are important for brain function. Its role in the regulation of neurotransmitter release, the formation of new neurons, and the regulation of cellular processes that are important for brain development and function makes it an attractive target for research and potential therapeutic intervention. Further studies are needed to fully understand the role of LOC730098 in the development and progression of neurological and psychiatric disorders, and to determine its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC730098

The "LOC730098 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC730098 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2 | LPAR1 | LPAR2 | LPAR3 | LPAR4 | LPAR5 | LPAR6 | LPCAT1 | LPCAT2 | LPCAT3 | LPCAT4 | LPGAT1 | LPIN1 | LPIN2 | LPIN3 | LPL | LPO | LPP | LPP-AS1 | LPP-AS2 | LPXN | LRAT | LRATD1 | LRATD2 | LRBA | LRCH1 | LRCH2 | LRCH3 | LRCH4 | LRCOL1 | LRFN1 | LRFN2 | LRFN3 | LRFN4 | LRFN5 | LRG1 | LRGUK | LRIF1 | LRIG1 | LRIG2 | LRIG2-DT | LRIG3 | LRIG3-DT | LRIT1 | LRIT2 | LRIT3 | LRMDA | LRP1 | LRP10 | LRP11 | LRP12 | LRP1B | LRP2 | LRP2BP | LRP3 | LRP4 | LRP4-AS1 | LRP5 | LRP5L | LRP6 | LRP8 | LRPAP1 | LRPPRC | LRR1 | LRRC1 | LRRC10 | LRRC10B | LRRC14 | LRRC14B | LRRC15